The Pharmacy Times® Pharmacy Hospital Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to hospital and health-system pharmacists.
November 26th 2024
Although shingles is more common in adults, children who have had chickenpox or the chickenpox vaccine can develop shingles.
ISMP Provides Recommendations for Avoiding COVID-19 Vaccination Administration Errors
January 15th 2021The recommendations focus on dilution errors, vaccine and monoclonal antibody mix-ups, waste of doses, administering immunizations to the wrong age group, errors with scheduling the second dose, and allergic reactions.
Read More
Pharmacists Are Moderately Satisfied With Compensation, Job Satisfaction, Survey Shows (Part 2)
January 8th 2021The first article in this 3-part series covered a general overview of the survey and its respondents. In this article, we will explore the questions and answers around compensation.
Read More
Managing Therapies in Patients With Cervical and Endometrial Cancers
January 5th 2021Pharmacists play a key role in educating patients on risk factors for cervical and endometrial cancers and can assist with treatment decisions, and management of potential adverse effects in patients with these cancers.
Read More
Pharmacists Are Moderately Satisfied with Compensation, Job Satisfaction, Survey Shows (Part 1)
December 31st 2020When asked to rate their satisfaction with their current annual total compensation on a scale of 1 to 7 (with 1 being “not at all” and 7 being “extremely”), the average response among the 299 respondents to that question was 4.82.
Read More
Survey Finds Younger Generations Have Least Amount of Trust in COVID-19 Vaccine
December 23rd 2020Emphasizing the importance of the COVID-19 vaccine to younger generations and those with no underlying health conditions could significantly increase the overall rate of vaccination in the United States.
Read More
European Medicines Committee Issues Positive Opinion for COVID-19 Vaccine From Pfizer, BioNTech
December 21st 2020The action allows for medicinal products to be authorized on a conditional basis for seriously debilitating or life-threatening diseases or for use in emergency situations in response to public health threats in the European Union.
Read More
FDA Approves Selinexor Combination Treatment for Certain Patients With Multiple Myeloma
December 19th 2020Selinexor (Xpovio; Karyopharm Therapeutics Inc.) in combination with bortezomib (Velcade; Takeda) and dexamethasone was approved for the treatment of adult patients with multiple myeloma who have received at least 1 prior therapy.
Read More
How the CDC’s COVID-19 Pharmacy Partnership for Long-Term Care Program Will Benefit 3 Groups
December 19th 2020Throughout the pandemic, we have taken an aggressive approach to service and safety, ensuring that there would be no disruption in services, and even expanding our offerings during these difficult times to include virtual onboarding and contactless delivery.
Read More
Understanding the 340B Prime Vendor Program and Supporting Stakeholders During COVID-19
December 15th 2020Under the 340B Prime Vendor Program, the Prime Vendor has several functions that it carries out to support stakeholders in operating and navigate the field so that they can effectively achieve lower 340B drug pricing for those who need it most.
Read More
Utilizing Education and Machine Learning to Establish an Opioid Prescription Stewardship Program
December 14th 2020Monitoring outpatient prescribing patterns has been a major challenge for the Lifespan health system in Rhode Island, since it has over 1.5 million electronic prescriptions written annually.
Read More